Thursday, July 18 • Vol 8, Issue 14

A Women’s Health Initiative study of a combination of the hormones estrogen and progestin, prescribed under the brand Prempro, was stopped early because of results indicating that the form of HRT increases risk of breast cancer and other diseases. Photo by Clay Eals

• Early end for HRT clinical trial
  Combination of estrogen and progestin proves more risky than healthful, triggering halt of first definitive, large, national study of hormone therapy
  
  
• She's from the mold school
  Kieren Marr's lab investigates the rapid rise of lethal diseases caused on transplant wards by ubiquitous — and typically harmless — organisms
  
  
• On the wings of knowledge
  Master-slave relationship of cell growth and cell cycle underlies fruit-fly research in the lab of Bruce Edgar
  
  
• ‘Couldn’t wait to do it myself’
  Excitement over scientific immersion fuels summer session for SEP, drawing teachers from all over the state, Texas and Singapore
  

• The data backbone
  In her 26th year, Janice Takashima knows that Wilms study has come a long way since center's pre-computer plotting of points on graph paper
  
  
• Say hello to Edson Park, named for philanthropist Orin Edson, at ribbon-cutting at 1 tomorrow
  

Briefs

• Dirk van Bekkum award goes to Peter Horn in Kiem's clinical lab
  
  
• July madness
  
  
• The Force for free
  
  
• Craft fair set Friday, Aug. 2
  
  
• Cello set for Healing Music
  
  
• Is your retirement on track? Find out more on Monday, Aug. 5
  
  
• Home-buying series continues Tuesday with look at whole process
  
• Human-subjects training set Thursday, Aug. 8, in Pelton
  
  
• Web Watch: Access 1,300 journals with one link
  
  
• Full-court press for diversity
  
  
• Fred Hutchinson/CIS booth at Pride Festival draws crowd; organizers plan for next year

Credits